Over 7,000 Volunteers Recruited in Q1 This Year!

Posted:
7
June 2004

Richmond Pharmacology is delighted to announce we recruited over 7,000 new volunteers between January and March of 2004. This takes the total number of volunteers registered to over 25,000 in just 2 years.Quarter two looks set to yield similar recruitment figures, with over 2,300 new volunteers registering every month. The result is a testimony to Richmond Pharmacology’s dedicated volunteer recruitment team:Wendy Galloway, Head of Volunteer Recruitment, commented: “Obviously the whole team is delighted with the results of our recruitment programme. Our wide ranging advertising campaigns are drawing in thousands of enquiries to our recruitment website www.trials4us.co.uk and our telerecruitment team. Richmond Pharmacology is conducting an ever growing number of studies, which puts the onus on successful, targeted volunteer recruitment. It means we are able to guarantee delivery of whatever type of volunteer panel our clients require. I look forward to continuing to grow our volunteer database at such a fast rate.”

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more